High-dose rituximab in the conditioning regimen before allogeneic stem cell transplantation for relapsed lymphomas: protective role of the antibody on GvHD incidence

被引：0
|
作者：
Corradini, P.
Sarina, B.
Carniti, C.
Patriarca, F.
Carella, A.
Levis, A.
Bosi, A.
Falda, M.
Di Bartolomeo, P.
Olivares, C.
Gimondi, S.
Rambaldi, A.
Dodero, A.
机构：
来源：
BONE MARROW TRANSPLANTATION | 2012年 / 47卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S421 / S421
页数：1
相关论文
共 50 条
  • [1] HIGH-DOSE RITUXIMAB IN THE CONDITIONING REGIMEN BEFORE ALLOGENEIC STEM CELL TRANSPLANTATION FOR RELAPSED B-CELL LYMPHOMAS IS ASSOCIATED WITH REDUCED GVHD-RELATED DEATHS, BUT DID NOT IMPROVE DISEASE CONTROL
    Dodero, A.
    Spina, F.
    Sarina, B.
    Carniti, C.
    Patriarca, F.
    Carella, A. M.
    Levis, A.
    Bosi, A.
    Falda, M.
    Di Raimondo, F.
    Di Bartolomeo, P.
    Dalto, S.
    Bacigalupo, A.
    Rambaldi, A.
    Corradini, P.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S288 - S288
  • [2] High-Dose Rituximab In The Conditioning Regimen Before Allogeneic Stem Cell Transplantation Decreases Deaths Related To Gvhd Without Affecting The Anti-Lymphoma Effect
    Dodero, Anna
    Spina, Francesco
    Sarina, Barbara
    Carniti, Cristiana
    Patriarca, Francesca
    Garella, Angelo Michele
    Levis, Alessandro
    Bosi, Alberto
    Falda, Michele
    Di Bartolomeo, Paolo
    Onida, Francesco
    Dalto, Serena
    Vendramin, Antonio
    Rambaldi, Alessandro
    Corradini, Paolo
    BLOOD, 2013, 122 (21)
  • [3] Reduced-intensity conditioning (RIC) with high-dose rituximab and allogeneic stem cell transplantation for relapsed CD20+lymphomas: good disease control with low incidence of chronic GVHD
    Dodero, A.
    Sarina, B.
    Milone, G.
    Patriarca, F.
    Bosi, A.
    Dominietto, A.
    Farina, L.
    Foa, R.
    Terruzzi, E.
    Onida, F.
    Rambaldi, A.
    Corradini, P.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S162 - S162
  • [4] Hiccups and severe hyponatremia associated with high-dose cyclophosphamide in conditioning regimen for allogeneic stem cell transplantation
    Lazarevic, V.
    Hagg, E.
    Wahlin, A.
    AMERICAN JOURNAL OF HEMATOLOGY, 2007, 82 (01) : 88 - 88
  • [5] Allogeneic stem cell transplantation using lymphoablative rather than myeloablative conditioning regimen for relapsed or refractory lymphomas
    Yoon, Jae-Ho
    Jeon, Young-Woo
    Lee, Sung-Eun
    Cho, Byung-Sik
    Eom, Ki-Seong
    Kim, Yoo-Jin
    Lee, Seok
    Kim, Hee-Je
    Min, Chang-Ki
    Lee, Jong-Wook
    Min, Woo-Sung
    Cho, Seok-Goo
    HEMATOLOGICAL ONCOLOGY, 2017, 35 (01) : 17 - 24
  • [6] Rituximab for indolent lymphomas before and after allogeneic hematopoietic stem cell transplantation
    Cieri, Nicoletta
    Di Bartolo, Orazio
    Corradini, Paolo
    CURRENT OPINION IN HEMATOLOGY, 2015, 22 (06) : 469 - 475
  • [7] High-dose BCNU/Melphalan conditioning regimen before autologous stem cell transplantation in newly diagnosed multiple myeloma
    D Sivaraj
    W Bacon
    G D Long
    D A Rizzieri
    M E Horwitz
    K M Sullivan
    Y Kang
    Z Li
    N J Chao
    C Gasparetto
    Bone Marrow Transplantation, 2018, 53 : 34 - 38
  • [8] High-dose BCNU/Melphalan conditioning regimen before autologous stem cell transplantation in newly diagnosed multiple myeloma
    Sivaraj, D.
    Bacon, W.
    Long, G. D.
    Rizzieri, D. A.
    Horwitz, M. E.
    Sullivan, K. M.
    Kang, Y.
    Li, Z.
    Chao, N. J.
    Gasparetto, C.
    BONE MARROW TRANSPLANTATION, 2018, 53 (01) : 34 - 38
  • [9] Increased incidence of renal impairment after radioimmunotherapy as part of the conditioning regimen before allogeneic stem cell transplantation
    Zenz, T.
    Schlenk, R.
    Glatting, G.
    Stilgenbauer, S.
    Schauwecker, S.
    von Harsdorf, S.
    Ringhoffer, M.
    Blumstein, N.
    Buchmann, I.
    Doehner, H.
    Reske, S.
    Bunjes, D.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S72 - S72
  • [10] Allogeneic Stem Cell Transplantation for Relapsed/Refractory B Cell Lymphomas: Results of a Multicenter Phase II Prospective Trial including Rituximab in the Reduced-Intensity Conditioning Regimen
    Dodero, Anna
    Patriarca, Francesca
    Milone, Giuseppe
    Sarina, Barbara
    Miceli, Rosalba
    Iori, Anna
    Barretta, Francesco
    Terruzzi, Elisabetta
    Mussetti, Alberto
    Pini, Massimo
    Bosi, Alberto
    Dominietto, Alida
    Cascavilla, Nicola
    Onida, Francesco
    Narni, Franco
    Farina, Lucia
    Rambaldi, Alessandro
    Corradini, Paolo
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (07) : 1102 - 1109
12345